title: [Kidney transplantation: indications, results, limitations, and perspectives].
abstract: In France, kidney transplantation is part of - and is reimbursed as - treatment for chronic kidney disease. Long-term survival and quality of life are better for transplant recipients than for dialysis patients. Stagnation in the survival rate of transplants over the past 10 years has led to the development of new immunosuppressive drugs to minimize the use of corticosteroids and anticalcineurins and to induce tolerance of the transplanted kidney. The scarcity and lower quality of kidneys for transplantation is also leading to the development of new transplantation sources: donors with cardiac arrest and elderly, living and ABO-incompatible donors.
authors.affiliation: Service de néphrologie-transplantation, Hôpital Henri Mondor, Créteil.
authors.forename: Marie
authors.initials: M
authors.lastname: Matignon
authors.forename: Karine
authors.initials: K
authors.lastname: Dahan
authors.forename: Ghislaine
authors.initials: G
authors.lastname: Fruchaud
authors.forename: Vincent
authors.initials: V
authors.lastname: Audard
authors.forename: Philippe
authors.initials: P
authors.lastname: Grimbert
authors.forename: Philippe
authors.initials: P
authors.lastname: Lang
mesh_terms: D006323:Heart Arrest; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000601:surgery*; D016030:Kidney Transplantation; D014019:Tissue Donors; D023001:Transplantation Tolerance
chemical_list: D007166:Immunosuppressive Agents